|
|
|
| Application of Bacteriophage in Aquaculture: Focusing on Problems and Solutions |
| LYU Ke1, ZHAO Qiancheng1, LIU Jingyi1, MA Zizhen1, XU Yongping2, MA Yongsheng1 |
1. College of Food Science and Engineering, Dalian Ocean University, Dalian 116023, China;
2. School of Bioengineering, Dalian University of Technology, Dalian 116024, China |
|
|
|
|
|
|
Received: 04 September 2019
|
|
|
|
|
|
[1]联合国粮食及农业组织. 2016年世界渔业和水产养殖状况[R]. 罗马:联合国粮食及农业组织,2016.
[2]农业农村部渔业渔政管理局,全国水产技术推广总站,中国水产学会. 2019中国渔业统计年鉴[M].北京:中国农业出版社,2019.
[3]吴淑勤,王亚军. 我国水产养殖病害控制技术现状与发展趋势[J]. 中国水产,2010(8):9-10.
[4]郭秀平,邓国成,杨小静. 我国现行水产养殖动物使用国标兽药的种类[J]. 海洋与渔业,2014(3):57-59.
[5]Liu X, Steele J C, Meng X. Usage, residue, and human health risk of antibiotics in Chinese aquaculture: a review [J]. Environmental Pollution,2017,223(1):161-169.
[6]Wu J L, Lin H M, Jan L, et al. Biological control of fish bacterial pathogen, Aeromonas hydrophila, by bacteriophage AH 1[J]. Fish Pathology,1981,15(3/4):271-276.
[7]Nakai T, Sugimoto R, Park K H, et al. Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail[J]. Diseases of Aquatic Organisms,1999,37(1):33-41.
[8]Kim J H, Gomez D K, Nakai T, et al. Isolation and identification of bacteriophages infecting ayu Plecoglossus altivelis altivelis specific Flavobacterium psychrophilum[J]. Veterinary Microbiology,2010,140(1/2):109-115.
[9]Verner Jeffreys D W, Algoet M, Pond M J, et al. Furunculosis in Atlantic salmon (Salmo salar L.) is not readily controllable by bacteriophage therapy[J]. Aquaculture,2007,270(1):475-484.
[10]Karunasagar I, Shivu M M, Girisha S K, et al. Biocontrol of pathogens in shrimp hatcheries using bacteriophages[J]. Aquaculture,2007,268(1):288-292.
[11]李太武,相建海,刘瑞玉,等. 噬菌体防治皱纹盘鲍脓疱病的研究[J]. 海洋与湖沼,1999,30(4):374-380.
[12]Zhang J C, Cao Z H, Li Z, et al. Effect of bacteriophages on Vibrio alginolyticus infection in the sea cucumber, Apostichopus japonicus (Selenka) [J]. Journal of the World Aquaculture Society,2015,46(2):149-158.
[13]Park S C, Nakai T. Bacteriophage control of Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelis[J]. Diseases of Aquatic Organisms,2003,53(1):33-39.
[14]Higuera G, Bastías R, Tsertsvadze G, et al. Recently discovered Vibrio anguillarum phages can protect against experimentally induced vibriosis in Atlantic salmon, Salmo salar[J]. Aquaculture,2013,392/393/394/395:128-133.
[15]Khairnar K, Raut M P, Chandekar R H, et al. Novel bacteriophage therapy for controlling metallo-beta- lactamase producing Pseudomonas aeruginosa infection in catfish[J]. BMC Veterinary Research,2013,9(1):264.
[16]Prasad Y, Kumar D, Sharma A K. Lytic bacteriophages specific to Flavobacterium columnare rescue catfish, Clarias batrachus (Linn.) from columnaris disease[J]. Journal of Environmental Biology,2011,32(2):161-168.
[17]Silva Y J, Moreirinha C, Pereira C, et al. Biological control of Aeromonas salmonicida infection in juvenile Senegalese sole (Solea senegalensis) with Phage AS-A[J]. Aquaculture,2016,450:225-233.
[18]Jun J W, Kim J H, Shin S P, et al. Protective effects of the Aeromonas phages pAh1-C and pAh6-C against mass mortality of the cyprinid loach (Misgurnus anguillicaudatus) caused by Aeromonas hydrophila[J]. Aquaculture,2013,416/417:289-295.
[19]Matsuoka S, Hashizume T, Kanzaki H, et al. Phage therapy against β-hemolytic streptococcicosis of Japanese flounder Paralichthys olivaceus[J]. Fish Pathology,2007,42(4):181-189.
[20]Imbeault S, Parent S, Lagacé M, et al. Using bacteriophages to prevent furunculosis caused by Aeromonas salmonicida in farmed brook trout[J]. Journal of Aquatic Animal Health,2006,18(3):203-214.
[21]Raghu Patil J, Desai S N, Roy P, et al. Simulated hatchery system to assess bacteriophage efficacy against Vibrio harveyi[J]. Diseases of Aquatic Organisms,2014,112(2):113-119.
[22]Lomelí-Ortega C O, Martínez-Díaz S F. Phage therapy against Vibrio parahaemolyticus infection in the whiteleg shrimp (Litopenaeus vannamei) larvae[J]. Aquaculture,2014,434:208-211.
[23]Wang Y, Barton M D, Elliott L, et al. Bacteriophage therapy for the control of Vibrio harveyi in greenlip abalone (Haliotis laevigata)[J]. Aquaculture,2017,473:251-258.
[24]EFSA Panel on Biological Hazards (BIOHAZ). Evaluation of the safety and efficacy of ListexTM P100 for reduction of pathogens on different ready-to-eat (RTE) food products[J]. EFSA Journal,2016,14(8):1-94.
[25]Matsuzaki S, Tanaka S, Koga T, et al. A broad-host-range vibriophage, KVP40, isolated from sea water[J]. Microbiology and Immunology,1992,36(1):93-97.
[26]Mahichi F, Synnott A J, Yamamichi K, et al. Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity[J]. FEMS Microbiology Letters,2009,295(2):211-217.
[27]Labrie S J, Samson J E, Moineau S. Bacteriophage resistance mechanisms[J]. Nature Reviews Microbiology,2010,8 (5):317-327.
[28]崔鹏,许涛,张文宏,等. 细菌持留与抗生素表型耐药机制[J]. 遗传,2016,38(10):859-871.
[29]Chan B K, Sistrom M, Wertz J E, et al. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa[J]. Scientific Reports,2016,6:26717.
[30]Dauble D D, Curtis L R. Influence of digestive processes on the absorption and fate of quinoline ingested by rainbow trout (Oncorhynchus mykiss)[J]. Environmental Toxicology and Chemistry,1990,9(4):505-512.
[31]Międzybrodzki R, Kłak M, Jończyk-Matysiak E, et al. Means to facilitate the overcoming of gastric juice barrier by a therapeutic staphylococcal bacteriophage A5/80[J]. Frontiers in Microbiology,2017,8:467.
[32]Ma Y, Pacan J C, Wang Q, et al. Enhanced alginate microspheres as means of oral delivery of bacteriophage for reducing Staphylococcus aureus intestinal carriage[J]. Food Hydrocolloids,2012,26(2):434-440.
[33]Ma Y S, Pacan J C, Wang Q, et al. Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery[J]. Applied and Environmental Microbiology,2008,74(15):4799-4805.
[34]Dabrowska K, Switala-Jelen K, Opolski A, et al. Bacteriophage penetration in vertebrates[J]. Journal of Applied Microbiology,2005,98(1):7-13.
[35]Abedon S T, Thomas-Abedon C. Phage therapy pharmacology[J]. Current Pharmaceutical Biotechnology,2010,11(1):28 -47.
[36]高蕾,罗理,姜兰,等.单次投喂乳酸诺氟沙星在鳜鱼体内的代谢消除规律[J].水产科学,2017,36(1):99-103.
[37]缪小群,曾振灵,刘志昌,等. 氟甲喹在罗非鱼体内的消除规律研究[J].水产科学,2014,33(8):512-515.
[38]Smith H W, Huggins M B. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics[J]. Journal of General Microbiology,1982,128(2):307-318.
[39]Madsen L, Bertelsen S K, Dalsgaard I, et al. Dispersal and survival of Flavobacterium psychrophilum phages in vivo in rainbow trout and in vitro under laboratory conditions:implications for their use in phage therapy [J]. Applied and Environmental Microbiology,2013,79(16):4853-4861.
[40]Martínez-Díaz S F, Hipólito-Morales A. Efficacy of phage therapy to prevent mortality during the vibriosis of brine shrimp[J]. Aquaculture,2013,400/401:120-124.
[41]Roach D R, Leung C Y, Henry M, et al. Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen[J]. Cell Host & Microbe,2017,22(1):38-47,e1-e4.
[42]Broxmeyer L, Sosnowska D, Miltner E, et al. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium:a model for phage therapy of intracellular bacterial pathogens[J]. The Journal of Infectious Diseases,2002,186(8):1155-1160.
[43]Payne R J, Jansen V A. Understanding bacteriophage therapy as a density-dependent kinetic process[J]. Journal of Theoretical Biology,2001,208(1):37-48.
[44]Secombes C. Will advances in fish immunology change vaccination strategies? [J]. Fish & Shellfish Immunology,2008,25(4):409-416.
[45]Matsuzaki S, Yasuda M, Nishikawa H, et al. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage Φ MR11[J]. The Journal of Infectious Diseases,2003,187(4):613-624.
[46]Majewska J, Beta W, Lecion D, et al. Oral application of T4 phage induces weak antibody production in the gut and in the blood[J]. Viruses,2015,7(8):4783-4799.
[47]Merril C R, Biswas B, Carlton R, et al. Long-circulating bacteriophage as antibacterial agents[J]. Proceedings of the National Academy of Sciences of the United States of America,1996,93(8):3188-3192.
[48]Atterbury R J. Bacteriophage biocontrol in animals and meat products[J]. Microbial Biotechnology,2009,2 (6):601-612.
[49]Kim K P, Cha J D, Jang E H, et al. PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response[J]. Microbial Biotechnology,2008,1(3):247-257.
[50]Li Z, Ren H, Li Q, et al. Exploring the effects of phage cocktails in preventing Vibrio infections in juvenile sea cucumber (Apostichopus japonicus) farming[J]. Aquaculture,2020,515:734599.
[51]Brüssow H, Hendrix R W. Phage genomics[J]. Cell,2002,108(1):13-16.
[52]Fuhrman J A. Marine viruses and their biogeochemical and ecological effects[J]. Nature,1999,399(6736):541-548.
[53]Calci K R, Burkhardt W Ⅲ, Watkins W D, et al. Occurrence of male-specific bacteriophage in feral and domestic animal wastes, human feces, and human-associated wastewaters[J]. Applied and Environmental Microbiology,1998,64(12):5027-5029.
[54]Bachrach G, Leizerovici-Zigmond M, Zlotkin A, et al. Bacteriophage isolation from human saliva[J]. Letters in Applied Microbiology,2003,36(1):50-53.
[55]Sukumaran A T, Nannapaneni R, Kiess A, et al. Reduction of Salmonella on chicken breast fillets stored under aerobic or modified atmosphere packaging by the application of lytic bacteriophage preparation Salmo FreshTM [J]. Poultry Science,2016,95(3):668-675.
[56]Waldor M K, Mekalanos J J. Lysogenic conversion by a filamentous phage encoding cholera toxin[J]. Science,1996,272(5270):1910-1914.
[57]Munro J, Oakey J, Bromage E, et al. Experimental bacteriophage-mediated virulence in strains of Vibrio harveyi[J]. Diseases of Aquatic Organisms,2003,54(3):187-194.
[58]Colavecchio A, Cadieux B, Lo A, et al. Bacteriophages contribute to the spread of antibiotic resistance genes among foodborne pathogens of the Enterobacteriaceae family－a review[J]. Frontiers in Microbiology,2017,8(6):1108.
[59]Dedrick R M, Guerrero-Bustamante C A, Garlena R A, et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus[J]. Nature Medicine,2019,25(5):730-733.
[60]Dedrick R M, Guerrero Bustamante C A, Garlena R A, et al. Mycobacteriophage ZoeJ:a broad host-range close relative of mycobacteriophage TM4[J]. Tuberculosis,2019,115:14-23.
[61]徐先栋,谢珍玉,王世锋,等.致病溶藻弧菌脂多糖对点带石斑鱼毒性和免疫原性的影响[J]. 海洋科学,2010,34(3):47-51.
[62]Matsuda T, Freeman T A, Hilbert D W, et al. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model[J]. Surgery,2005,137(6):639-646. |
|
|
|
